Toledo, OHNCT07228026Now EnrollingIRB Ready

Asthma Clinical Trial in Toledo, OH

Access cutting-edge asthma treatment through this clinical trial at a research site in Toledo. Study-provided care at no cost to qualified participants.

Sponsored by Biometry Inc

Quick Self-Assessment

See if you qualify for this Toledo location

Preparing your pre-screening questions…

Expert Care in Toledo

Access asthma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related asthma treatment provided free

Apply for This Toledo Location

Check if you qualify for this asthma clinical trial in Toledo, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Toledo

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Toledo site if eligible
  4. 4Begin participation

About This Asthma Study in Toledo

This study incorporates objectives directed at two subject cohorts: 1. Uncontrolled Adult and Pediatric Asthma Subjects: To demonstrate a statistically significant and clinically meaningful decline in Point Of Care (POC) FeNO as measured by the fenoTRACK device, after an approximately 2-week course of corticosteroid therapy in adults and children with non-steroid treated uncontrolled asthma. 2. Controlled Adult and Pediatric Asthma Subjects: * To evaluate within-session clinical precision during Visit 1 and Visit 2 for the fenoTRACK device for simulated at home FeNO, and at POC * To evaluate within-session clinical precision for home fenoTRACK use

Sponsor: Biometry Inc

Who Can Participate

Inclusion Criteria

Uncontrolled Cohort:
The subject is male or female age 5 years and above
The subject and/or their Legally Authorized Representative (LAR) in the case of a minor has signed an Informed Consent Form (ICF) and Assent (as applicable per IRB requirements) and understands the risks and benefits of the study
The subject has a diagnosis of asthma
The subject is willing and able to perform all study procedures
The subject must have uncontrolled asthma as defined by the presence on at least 2 days per week (can be non-consecutive days) in the 7 days prior to V1 of at least 3 symptoms from the following list: i. Cough ii. Wheezing iii. Shortness of breath iv. Chest tightness v. Nocturnal awakening with asthma vi. Limitation in activity due to asthma
The subject has a FeNO value based on the first measurement of at least 30 ppb if an adult or at least 25 ppb if \<18 years old measured on a cleared FeNO device (e.g., NIOX VERO®) Inclusion Criteria Controlled Cohort:
The subject is male or female age 5 years and above
The subject and/or their Legally Authorized Representative (LAR) in the case of a minor has signed an Informed Consent Form (ICF) and Assent (as applicable per IRB requirements) and understands the risks and benefits of the study
The subject has an established diagnosis of asthma for at least 180 days prior to V1
The subject is willing and able to perform all study procedures

Exclusion Criteria

Uncontrolled:
The subject is in need of immediate referral to the emergency department
The subject has taken the following medications in the indicated period before V1:
OCS within 4 weeks
ICS within 2 weeks
Biologic therapies (e.g., omalizumab or dupilumab) within 12 weeks. Note: Use of as needed ICS+SABA is also exclusionary in the 2 weeks prior to V1
The subject has a contraindication to corticosteroids.
The subject has demonstrated significant non-compliance during a previous clinical trial
The subject participated in any clinical study involving a drug, biologic, or device within 30 days prior to V1 or within 5 half-lives for drugs, whichever duration is shorter
The subject has other significant respiratory conditions, e.g., Chronic Obstructive Pulmonary Disease, cystic fibrosis
Subject is an employee/relative of the following:
Biometry Inc.
Contract Research Organization(s) running the study
Investigational Site
Study Vendors
Any other condition(s), that in the Investigator's opinion, make it undesirable for the subject to participate in the study
A ≥ 10 pack-year history of smoking or smoking in the 180 days prior to V1 (pack years = average packs/day x years of exposure) Note: smoking includes cigarettes, electronic cigarettes, cigars, and chewing or dipping tobacco
Pregnant or nursing subjects Exclusion Criteria Controlled:
The subject has other significant respiratory conditions, e.g., Chronic Obstructive Pulmonary Disease, cystic fibrosis
The subject has demonstrated significant non-compliance during a previous clinical trial
The subject participated in any clinical study involving a drug, biologic, or device within 30 days prior to V1 or within 5 half-lives for drugs, whichever duration is shorter.
Subject is an employee/relative of the following:
Biometry Inc.
Contract Research Organization(s) running the study
Investigational Site
Study Vendors
Any other condition(s), that in the Investigator's opinion, make it undesirable for the subject to participate in the study
A ≥ 10 pack-year history of smoking or smoking in the 180 days prior to V1 (pack years = average packs/day x years of exposure) Note: smoking includes cigarettes, electronic cigarettes, cigars, and chewing or dipping tobacco
Pregnant or nursing subjects

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Toledo?

Yes, this clinical trial (NCT07228026) has an active research site in Toledo, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Asthma Treatment Options in Toledo, OH

If you're searching for asthma treatment options in Toledo, OH, this clinical trial (NCT07228026) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Toledo research site is actively enrolling participants for this clinical trial. You'll receive care from experienced asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all asthma clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Toledo, OH

See all ankylosing spondylitis clinical trials recruiting in Toledo — not just this study.

Browse Ankylosing Spondylitis Trials in Toledo →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsAsthma TrialsPediatric Asthma TrialsModerate-to-Severe Asthma TrialsAll Conditions →

Ready to Join in Toledo?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Toledo, OH